Xylem (NYSE:XYL) Stock Price Target Lowered at BNP Paribas Exane

Xylem (NYSE:XYL) had its price objective dropped by analysts at BNP Paribas Exane from $145.00 to $135.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the industrial products company’s stock. BNP Paribas Exane‘s price target would suggest a potential upside of 53.18% from the company’s current price.

XYL has been the topic of a number of other reports. Jefferies Financial Group increased their price objective on shares of Xylem from $145.00 to $150.00 and gave the stock a “buy” rating in a research note on Monday, August 24th. Stifel Nicolaus decreased their price objective on shares of Xylem from $141.00 to $114.00 and set a “buy” rating on the stock in a research note on Wednesday. Citigroup lowered their price objective on shares of Xylem from $172.00 to $148.00 and set a “buy” rating for the company in a research report on Monday, October 12th. The Goldman Sachs Group restated a “buy” rating and set a $138.00 target price (down from $160.00) on shares of Xylem in a research note on Wednesday. Finally, Barclays reduced their target price on Xylem from $159.00 to $139.00 and set an “overweight” rating on the stock in a report on Tuesday, October 13th. Ten equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $129.50.

Xylem Stock Performance

Xylem stock traded down $4.73 during midday trading on Wednesday, reaching $88.13. 6,043,065 shares of the company’s stock were exchanged, compared to its average volume of 2,131,106. Xylem has a 52 week low of $87.40 and a 52 week high of $154.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61. The firm has a market cap of $20.58 billion, a price-to-earnings ratio of 20.98, a P/E/G ratio of 1.75 and a beta of 1.00. The stock’s 50-day simple moving average is $106.50 and its 200 day simple moving average is $118.31.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a return on equity of 11.77% and a net margin of 11.15%. The firm had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.28 billion. During the same period in the previous year, the business posted $1.37 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. On average, analysts expect that Xylem will post 5.65 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Xylem

A number of institutional investors have recently added to or reduced their stakes in XYL. Renaissance Investment Group LLC grew its position in Xylem by 5.8% during the third quarter. Renaissance Investment Group LLC now owns 88,230 shares of the industrial products company’s stock valued at $8,935,000 after buying an additional 4,823 shares during the period. Soltis Investment Advisors LLC purchased a new position in Xylem during the 3rd quarter valued at about $6,895,000. Choreo LLC purchased a new stake in Xylem in the 3rd quarter worth approximately $248,000. North Star Investment Management Corp. raised its holdings in shares of Xylem by 21.4% in the 3rd quarter. North Star Investment Management Corp. now owns 1,701 shares of the industrial products company’s stock valued at $172,000 after acquiring an additional 300 shares in the last quarter. Finally, William Mack & Associates Inc. bought a new position in shares of Xylem in the 3rd quarter worth $25,000. 87.96% of the stock is owned by institutional investors.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Third-quarter adjusted EPS increased to $1.44 from $1.37 a year earlier, while orders reportedly rose 10%, suggesting some underlying demand resilience. However, these gains were not enough to offset the revenue shortfall and weaker guidance. Xylem Q3 2026 results
• Positive Sentiment: Stifel Nicolaus retained a “buy” rating with a $114 price target, while Oppenheimer maintained “outperform” at $135. These targets imply substantial recovery potential if Xylem executes its restructuring and business reset. Stifel Nicolaus rating
• Neutral Sentiment: Xylem plans divestitures and a segment restructuring as part of a portfolio reset. The changes could improve focus and profitability over time, but they also introduce execution risk and may weigh on results in the near term. Xylem outlook and restructuring
• Negative Sentiment: Revenue fell 3% year over year to $2.20 billion, about $80 million below expectations, and EPS missed consensus. Weak metering demand and project timing pressured sales. Xylem Q3 revenue miss
• Negative Sentiment: Management lowered its 2026 revenue and profit outlook and issued a weak fourth-quarter forecast, signaling that near-term headwinds are more severe than previously expected. Xylem lowered outlook
• Negative Sentiment: JPMorgan downgraded Xylem to “neutral” and cut its price target to $90 from $118. RBC also reduced its target to $125, and Oppenheimer lowered its target to $135, reflecting broad estimate revisions. JPMorgan Xylem downgrade
• Negative Sentiment: Put-option volume surged to more than four times its average, indicating increased hedging or bearish speculation. A law firm also announced an investigation into potential securities-law violations following the earnings-related losses. Xylem investigation notice

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.